Cornerstone Capital’s Gilead Sciences GILD Stock Holding History

Cornerstone Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.99M	Buy	35,818 +44	+0.1%	+$6.16K	0.5%	43
2025 Q4	$4.39M	Hold	35,774	–	–	0.43%	47
2025 Q3	$3.97M	Buy	35,774 +230	+0.6%	+$26.1K	0.39%	49
2025 Q2	$3.94M	Buy	35,544 +555	+2%	+$59.1K	0.41%	49
2025 Q1	$3.92M	Sell	34,989 -119	-0.3%	-$12.3K	0.42%	49
2024 Q4	$3.24M	Sell	35,108 -255	-0.7%	-$23K	0.34%	47
2024 Q3	$2.96M	Sell	35,363 -171	-0.5%	-$13K	0.28%	52
2024 Q2	$2.44M	Sell	35,534 -4,060	-10%	-$271K	0.25%	51
2024 Q1	$2.9M	Sell	39,594 -5,780	-13%	-$444K	0.3%	49
2023 Q4	$3.68M	Hold	45,374	–	–	0.4%	46
2023 Q3	$3.4M	Sell	45,374 -285	-0.6%	-$21.9K	0.41%	46
2023 Q2	$3.52M	Buy	45,659 +500	+1%	+$39.9K	0.41%	46
2023 Q1	$3.75M	Buy	45,159 +1,100	+2%	+$91.1K	0.45%	44
2022 Q4	$3.78M	Buy	44,059 +1,305	+3%	+$103K	0.48%	42
2022 Q3	$2.64M	Buy	42,754 +825	+2%	+$52K	0.37%	45
2022 Q2	$2.59M	Sell	41,929 -3,200	-7%	-$198K	0.33%	45
2022 Q1	$2.68M	Sell	45,129 -4,381	-9%	-$280K	0.3%	46
2021 Q4	$3.6M	Sell	49,510 -2,300	-4%	-$158K	0.38%	41
2021 Q3	$3.62M	Buy	51,810 +4,985	+11%	+$350K	0.42%	40
2021 Q2	$3.22M	Sell	46,825 -115	-0.2%	-$7.68K	0.37%	41
2021 Q1	$3.03M	Sell	46,940 -617	-1%	-$39.8K	0.37%	42
2020 Q4	$2.77M	Sell	47,557 -110	-0.2%	-$6.64K	0.36%	38
2020 Q3	$3.01M	Buy	47,667 +4,910	+11%	+$340K	0.43%	37
2020 Q2	$3.29M	Buy	42,757 +1,951	+5%	+$150K	0.56%	32
2020 Q1	$3.05M	Buy	40,806 +3,936	+11%	+$272K	0.63%	31
2019 Q4	$2.4M	Sell	36,870 -1,776	-5%	-$116K	0.34%	43
2019 Q3	$2.45M	Sell	38,646 -50	-0.1%	-$3.27K	0.38%	41
2019 Q2	$2.61M	Hold	38,696	–	–	0.41%	40
2019 Q1	$2.52M	Buy	38,696 +5,175	+15%	+$344K	0.42%	39
2018 Q4	$2.1M	Sell	33,521 -33,525	-50%	-$2.34M	0.37%	43
2018 Q3	$5.18M	Buy	67,046 +1,575	+2%	+$119K	0.79%	33
2018 Q2	$4.64M	Buy	65,471 +955	+1%	+$67.4K	0.79%	32
2018 Q1	$4.86M	Buy	64,516 +1,550	+2%	+$123K	0.8%	34
2017 Q4	$4.51M	Buy	62,966 +11,730	+23%	+$891K	0.77%	36
2017 Q3	$4.15M	Buy	51,236 +2,070	+4%	+$158K	0.73%	39
2017 Q2	$3.48M	Buy	49,166 +3,260	+7%	+$217K	0.66%	39
2017 Q1	$3.12M	Sell	45,906 -270	-0.6%	-$19K	0.61%	40
2016 Q4	$3.31M	Buy	46,176 +18,740	+68%	+$1.39M	0.71%	41
2016 Q3	$2.17M	Buy	27,436 +2,030	+8%	+$165K	0.47%	39
2016 Q2	$2.12M	Buy	25,406 +116	+0.5%	+$10.3K	0.46%	39
2016 Q1	$2.32M	Buy	25,290 +880	+4%	+$79.4K	0.51%	39
2015 Q4	$2.47M	Buy	24,410 +2,455	+11%	+$255K	0.56%	37
2015 Q3	$2.16M	Buy	21,955 +302	+1%	+$33.5K	0.54%	39
2015 Q2	$2.54M	Buy	21,653 +2,533	+13%	+$277K	0.58%	36
2015 Q1	$1.88M	Sell	19,120 -2,193	-10%	-$223K	0.49%	36
2014 Q4	$2.01M	Sell	21,313 -1,125	-5%	-$116K	0.53%	35
2014 Q3	$2.39M	Sell	22,438 -155	-0.7%	-$15.2K	0.66%	32
2014 Q2	$1.87M	Buy	22,593 +912	+4%	+$71K	0.5%	35
2014 Q1	$1.54M	Sell	21,681 -1,062	-5%	-$83.3K	0.44%	34
2013 Q4	$1.71M	Sell	22,743 -392	-2%	-$27.3K	0.5%	35
2013 Q3	$1.45M	Sell	23,135 -1,819	-7%	-$109K	0.44%	35
2013 Q2	$1.28M	Buy	+24,954	New	+$1.3M	0.42%	36

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Cornerstone Capital's GILD Position: Q1 2026 in Review

Cornerstone Capital increased its Gilead Sciences (GILD) stake by 0.12% in Q1 2026, buying an estimated $6.16K and bringing the position to 35,818 shares worth $4.99M. The position accounts for 0.5% of the portfolio, ranked #43.

Cornerstone Capital first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.18M in Q3 2018. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Cornerstone Capital held 35,818 shares of Gilead Sciences worth $4.99M as of Q1 2026.
Cornerstone Capital bought 44 Gilead Sciences shares in Q1 2026, an estimated $6.16K.
Gilead Sciences made up 0.5% of Cornerstone Capital's portfolio in Q1 2026, its #43 holding.
Cornerstone Capital first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
Cornerstone Capital's Gilead Sciences position peaked at $5.18M in Q3 2018.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Cornerstone Capital's 13F filing for Q1 2026, filed 12 May 2026.